Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Recruiting1
Other3

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT01950351Phase 2Active Not Recruiting
Hypofractionated Proton Beam Therapy for Localized Prostate Cancer
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7
PrincipalinvestigatorStart date: 2013-10-10
NCT01893307Phase 3Active Not Recruiting
Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer
Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7
PrincipalinvestigatorStart date: 2013-08-26
NCT01627093Active Not Recruiting
Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy
Head and Neck Carcinoma
PrincipalinvestigatorStart date: 2012-01-06
NCT00991094Recruiting
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Breast CarcinomaEsophageal CarcinomaGenitourinary System Carcinoma+6 more
PrincipalinvestigatorStart date: 2005-05-27

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeremie Calais

UCLA / Jonsson Comprehensive Cancer Center

Related
9 trials

Shared therapeutic areas:

Malignant Solid NeoplasmBreast CarcinomaEsophageal Carcinoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Arya Amini

City of Hope Medical Center

Related
7 trials

Shared therapeutic areas:

Head and Neck CarcinomaLung CarcinomaMalignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmHead and Neck CarcinomaMalignant Solid Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score6%

Anurag K Singh

Roswell Park Cancer Institute

Related
8 trials

Shared therapeutic areas:

Head and Neck CarcinomaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Kerri Winters-Stone

OHSU Knight Cancer Institute

Related
8 trials

Shared therapeutic areas:

Breast CarcinomaMalignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Anurag Singh

Roswell Park Cancer Institute

Related
10 trials

Shared therapeutic areas:

Breast CarcinomaHead and Neck CarcinomaLung Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Glenn Lesser, MD

Wake Forest University Health Sciences

Related
10 trials

Shared therapeutic areas:

Breast CarcinomaMalignant Digestive System Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

William D Figg, Pharm.D.

National Cancer Institute (NCI)

Related
11 trials

Shared therapeutic areas:

Breast CarcinomaLung Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Jeffrey Y Wong

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Breast CarcinomaMalignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT01950351Phase 2PrincipalInvestigator

Hypofractionated Proton Beam Therapy for Localized Prostate Cancer

Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7
Active Not Recruiting
NCT01893307Phase 3PrincipalInvestigator

Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer

Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7
Active Not Recruiting
NCT01627093PrincipalInvestigator

Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy

Head and Neck Carcinoma
Active Not Recruiting
NCT00991094PrincipalInvestigator

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Breast CarcinomaEsophageal CarcinomaGenitourinary System Carcinoma+6 more
Recruiting

All 4 trials loaded